Exhibit 1 JOINT FILING AGREEMENT PURSUANT TO RULE 13d-1(k)(1) ---------------------------- The undersigned acknowledge and agree that the foregoing statement on Schedule 13D is filed on behalf of each of the undersigned and that all subsequent...Joint Filing Agreement • March 28th, 2000 • Shafran Irving • Pharmaceutical preparations
Contract Type FiledMarch 28th, 2000 Company IndustryThe undersigned acknowledge and agree that the foregoing statement on Schedule 13D is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13D shall be filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934 without the necessity of filing additional joint filing agreements. This Agreement may be executed in any number of counterparts and all of such counterparts taken together shall constitute one and the same instrument.
JOINT FILING AGREEMENT PURSUANT TO RULE 13d-1(k)(1) The undersigned hereby agree that the statement on Schedule 13G with respect to the shares of Schein Pharaceutical, Inc. dated as of June 15, 1998 is, and any amendments thereto (including any...Joint Filing Agreement • August 3rd, 1998 • Shafran Irving • Pharmaceutical preparations
Contract Type FiledAugust 3rd, 1998 Company IndustryThe undersigned hereby agree that the statement on Schedule 13G with respect to the shares of Schein Pharaceutical, Inc. dated as of June 15, 1998 is, and any amendments thereto (including any amendments on Schedule 13D) signed by each of the undersigned shall be, filed on behalf of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934.